Nosis are still unknown. The limited variety of individuals in the literature have presented in various clinical stages and received different remedy combinations therefore the data summarized within this overview ought to be interpreted cautiously. Consent Written informed consent was obtained in the patient for publication of this case report and any accompanying pictures. A copy of the written consent is accessible for evaluation by the Editor-in-Chief of this journal.Angarita et al. Globe Journal of Surgical Oncology 2013, 11:128 http://www.wjso/content/11/1/Page 10 of13. van Krimpen C, Elferink A, Broodman CA, Hop WC, Pronk A, Menke M: The prognostic influence of neuroendocrine differentiation in breast cancer: benefits of a long-term follow-up study. Breast 2004, 13:32933. 14. Gunhan-Bilgen I, Zekioglu O, Ustun EE, Memis A, Erhan Y: Neuroendocrine differentiated breast carcinoma: imaging capabilities correlated with clinical and histopathological findings. Eur Radiol 2003, 13:78893. 15. Lopez-Bonet E, Alonso-Ruano M, Barraza G, Vazquez-Martin A, Bernado L, Menendez JA: Strong neuroendocrine breast carcinomas: Incidence, clinico-pathological features and Immunohistochemical profiling. Oncol Rep 2008, 20:1369374. 16. Jundt G, Schultz A, Heitz PU, Osborn M: Smaller cell neuroendocrine (oat cell) carcinoma of your male breast: immunocytochemical and ultrastructural investigations. Virchows Arch 1984, 404:21322. 17. Papotti M, Tanda F, Bussolati G, Pugno F, Bosincu L, Massareli G: Argyrophlic neuroendocrine carcinoma in the male breast. Ultrastruct Pathol 1993, 17:11521. 18. Wade MP, Mills SE, Read M, Cloud W, Lambert MJ, Smith RE: Tiny cell neuroendocrine (oat cell) carcinoma on the breast. Cancer 1983, 52:12125. 19. Papotti M, Gherardi G, Euebi V, Pagani A, Bussolati G: Principal oat cell (neuroendocrine) carcinoma of your breast. Report of four cases. Virchows Arch A Pathol Anat Histopathol 1992, 420:10308. 20. Francois A, Chatikhine VA, Chevallier B, Ren GS, Berry M, Chevrier A, Delpech B: Neruoendocrine main compact cell carcinoma of the breast. Report of a case and evaluation from the literature.Moxifloxacin Hydrochloride Am J Clin Oncol 1995, 18:13338.Mirabegron 21.PMID:32472497 Chua RS, Torno RB, Vuletin JC: Fine needle aspiration cytology of compact cell neuroendocrine carcinoma with the breast. A case report. Acta Cytol 1997, Suppl 4:134. 22. Fukunaga M, Ushigome S: Compact cell (oat cell) carcinoma with the breast. Pathology Int 1998, 48:74448. 23. Samli B, Celik S, Evrensel T, Orhan B, Tasdelen I: Primary neuroendocrine compact cell carcinoma of your breast. Arch Pathol Lab Med 2000, 124:29698. 24. Shin SJ, DeLellis RA, Ying L, Rosen PP: Little cell carcinoma of your breast: a clinicopathologic and immunohistochemical study of nine individuals. Am J Surg Pathol 2000, 24:1231238. 25. Yamasaki T, Shimazaki H, Aida S, Tamai S, Yamaki K, Hiraide H, Mochizuki H, Matsubara O: Key smaller cell (oat cell) carcinoma with the breast: report of a case and evaluation of your literature. Pathology Int 2000, 50:91418. 26. Salmo EN, Connolloy CE: Primary tiny cell carcinoma with the breast: report of a case and critique on the literature. Histopathology 2001, 38:27780. 27. Zekioglu O, Erhan Y, Ciris M, Bayramoglu H: Neuroendocrine differentiated carcinomas with the breast: a distinct entity. Breast 2003, 12:25157. 28. Bergman S, Hoda SA, Geisinger KR, Creager AJ, Trupiano JK: E-cadherin-negative main little cell carcinoma on the breast. Am J Clin Pathol 2004, 121:11721. 29. Bigotti G, Coli A, Butti A, del Vecchio M, Tartaglione R, Massi G: Pr.